Cellular and molecular events controlling skeletal muscle mass in response to altered use
- 12 January 2008
- journal article
- review article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 456 (3) , 587-600
Abstract
Gain or loss of skeletal muscle mass occurs in situations of altered use such as strength training, aging, denervation, or immobilization. This review examines our current understanding of the cellular and molecular events involved in the control of muscle mass under conditions of muscle use and disuse, with particular attention to the effects of resistance exercise/training. The DNA content, which is a critical determinant of protein synthesis by providing the amount of DNA necessary to sustain gene transcription, can be either increased (activation of satellite cells) or decreased (apoptosis) depending on muscle activity and ongoing physiological processes. In addition, several transcription factors are sensitive to functional demand and may control muscle-specific protein expression to promote or repress myofiber enlargement. The control of skeletal muscle mass is also markedly mediated by the regulation of transduction pathways that promote the synthesis and/or the degradation of proteins. Insulin-like growth factor-I plays a key role in this balance by activating the Akt/tuberous sclerosis complex 2/mammalian target of rapamycin pathway. Stimulation of this pathway leads to the concomitant activation of initiation and elongation factors resulting in the elevation of protein translation and the downregulation of ubiquitin proteasome components through Forkhead-box O transcription factors.Keywords
This publication has 168 references indexed in Scilit:
- NF-κB Regulation of YY1 Inhibits Skeletal Myogenesis through Transcriptional Silencing of Myofibrillar GenesMolecular and Cellular Biology, 2007
- Prevention of unloading-induced atrophy by vitamin E supplementation: Links between oxidative stress and soleus muscle proteolysis?Free Radical Biology and Medicine, 2007
- Musclin gene expression is strongly related to fast-glycolytic phenotypeBiochemical and Biophysical Research Communications, 2007
- Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humansThe Journal of Physiology, 2007
- The ubiquitin‐protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tensionThe FASEB Journal, 2006
- PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcriptionProceedings of the National Academy of Sciences of the United States of America, 2006
- Akt signalling through GSK‐3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophyThe Journal of Physiology, 2006
- Muscle atrophy in transgenic mice expressing a human TSC1 transgeneFEBS Letters, 2006
- Myogenic factors that regulate expression of muscle-specific microRNAsProceedings of the National Academy of Sciences, 2006
- Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin LigaseJournal of Biological Chemistry, 2005